Isabelle Mercier, Ph.D.
Affiliations: | 2004 | Université de Montréal, Montréal, Canada |
Area:
Molecular Biology, BiochemistryGoogle:
"Isabelle Mercier"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Angelino Calderone | grad student | 2004 | Université de Montréal | |
| (Effets de l'hormonotherapie et de ses alternatives sur le systeme cardiovasculaire.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dees S, Pontiggia L, Jasmin JF, et al. (2020) Phosphorylated STAT3 (Tyr705) as a biomarker of response to pimozide treatment in triple-negative breast cancer. Cancer Biology & Therapy. 1-16 |
| Chilewski SD, Bhosale D, Dees S, et al. (2020) Development of CAPER peptides for the treatment of triple negative breast cancer. Cell Cycle (Georgetown, Tex.). 1-16 |
| Campbell MC, Pontiggia L, Russell AY, et al. (2018) CAPER as a therapeutic target for triple negative breast cancer. Oncotarget. 9: 30340-30354 |
| Fultang N, Klase Z, Mercier I, et al. (2018) Abstract P5-07-13: MicroRNA-mediated restoration of tamoxifen sensitivity in triple negative breast cancer through modulation of estrogen receptor alpha/beta ratio using Myrothamnus flabellifolius Cancer Research. 78 |
| Mercier I, Gonzales DM, Quann K, et al. (2014) CAPER, a novel regulator of human breast cancer progression. Cell Cycle (Georgetown, Tex.). 13: 1256-64 |
| Danilo C, Gutierrez-Pajares JL, Mainieri MA, et al. (2013) Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development Breast Cancer Research. 15 |
| Quann K, Gonzales DM, Mercier I, et al. (2013) Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide Cell Cycle. 12: 1510-1520 |
| Mercier I, Camacho J, Titchen K, et al. (2012) Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug. The American Journal of Pathology. 181: 278-93 |
| Mercier I, Lisanti MP. (2012) Caveolin-1 and breast cancer: a new clinical perspective. Advances in Experimental Medicine and Biology. 729: 83-94 |
| Bryant KG, Camacho J, Jasmin JF, et al. (2011) Caveolin-1 overexpression enhances androgen-dependent growth and proliferation in the mouse prostate. The International Journal of Biochemistry & Cell Biology. 43: 1318-29 |